BBall Fantasy
Sign in
Standard 9-cat
12 teams · 9 cats
BBall Fantasy
Sign in
Standard 9-cat
12 teams · 9 cats
UTA · C · 9 seasons
| SEASON | TEAM | GP | MIN | FG | FG% | 3PT | 3P% | FT | FT% | OR | DR | REB | AST | BLK | STL | PF | TO | PTS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-19 | ORL | 47 | 16.3 | 2.5-5.2 | 48.1 | 0.4-1.5 | 30.0 | 0.8-1.3 | 58.7 | 1.4 | 3.6 | 5.0 | 0.8 | 1.4 | 0.3 | 2.2 | 0.9 | 6.2 |
| 2019-20 | ORL | 62 | 14.2 | 2.1-4.6 | 46.2 | 0.6-1.7 | 34.6 | 0.5-0.7 | 67.4 | 1.6 | 3.3 | 4.9 | 0.7 | 1.4 | 0.4 | 1.9 | 0.7 | 5.4 |
| 2020-21 | ORL | 46 | 15.8 | 3.1-6.5 | 47.2 | 0.8-2.6 | 32.2 | 1.0-1.4 | 68.2 | 1.7 | 4.1 | 5.8 | 0.8 | 1.3 | 0.3 | 1.9 | 0.8 | 8.0 |
| 2021-22 | ORL | 71 | 25.7 | 4.2-8.7 | 48.0 | 1.5-4.0 | 38.1 | 0.8-1.0 | 78.1 | 2.1 | 6.0 | 8.1 | 1.2 | 1.7 | 0.5 | 2.6 | 1.1 | 10.6 |
| 2022-23 | LAL | 49 | 15.7 | 2.4-4.9 | 48.5 | 1.0-2.5 | 38.7 | 0.8-1.3 | 66.1 | 1.2 | 3.4 | 4.6 | 0.9 | 0.9 | 0.3 | 2.1 | 0.6 | 6.6 |
| 2023-24 | PHI | 57 | 13.0 | 1.7-3.5 | 49.0 | 0.4-1.1 | 39.1 | 0.6-0.9 | 68.0 | 1.4 | 2.8 | 4.2 | 0.7 | 1.1 | 0.4 | 1.8 | 0.7 | 4.4 |
| 2024-25 | NOP | 32 | 12.9 | 1.6-3.5 | 46.4 | 0.5-1.7 | 27.8 | 0.6-0.8 | 70.4 | 1.0 | 3.5 | 4.5 | 0.6 | 1.0 | 0.3 | 1.8 | 0.6 | 4.3 |
| 2025-26 | UTA | 4 | 11.0 | 1.3-2.8 | 45.5 | 0.0-0.0 | - | 0.0-0.0 | - | 2.5 | 3.0 | 5.5 | 0.3 | 0.8 | 0.0 | 1.5 | 0.5 | 2.5 |
| 2026-27 | UTA | 6 | 17.4 | 3.3-4.5 | 74.1 | 0.0-0.0 | - | 1.0-1.5 | 66.7 | 2.5 | 3.5 | 6.0 | 0.7 | 1.7 | 0.3 | 1.2 | 0.5 | 7.7 |
| Career | 374 | 16.7 | 2.6-5.4 | 48.0 | 0.8-2.2 | 35.6 | 0.7-1.1 | 68.2 | 1.6 | 3.9 | 5.4 | 0.8 | 1.3 | 0.4 | 2.0 | 0.8 | 6.7 |
Games started is not in our data, so it is not a column here. Everything else is every regular season game he played.
What those averages were worth against the players around him that year. A season is its own league, so these do not add up across rows.
| SEASON | TEAM | FG% | FT% | 3PM | PTS | REB | AST | STL | BLK | TO | RANK |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-19 | ORL | +0.30 | -0.97 | -0.53 | -0.39 | +0.53 | -0.61 | -0.82 | +2.41 | +0.19 | 223 of 530 |
| 2019-20 | ORL | +0.07 | -0.28 | -0.40 | -0.53 | +0.50 | -0.70 | -0.62 | +2.40 | +0.54 | 192 of 529 |
| 2020-21 | ORL | +0.16 | -0.54 | -0.19 | -0.15 | +0.89 | -0.66 | -0.81 | +2.09 | +0.37 | 187 of 540 |
| 2021-22 | ORL | +0.46 | +0.07 | +0.69 | +0.38 | +1.92 | -0.37 | -0.17 | +3.45 | -0.09 | 51 of 605 |
| 2022-23 | LAL | +0.14 | -0.54 | -0.01 | -0.37 | +0.45 | -0.58 | -0.86 | +1.30 | +0.60 | 228 of 539 |
| 2023-24 | PHI | +0.16 | -0.41 | -0.57 | -0.59 | +0.33 | -0.68 | -0.52 | +1.59 | +0.37 | 276 of 572 |
| 2024-25 | NOP | +0.03 | -0.27 | -0.64 | -0.70 | +0.39 | -0.84 | -0.92 | +1.40 | +0.56 | 310 of 569 |
| 2025-26 | UTA | -0.07 | — | -1.20 | -1.04 | +0.82 | -1.06 | -1.65 | +0.91 | +0.77 | 391 of 582 |
| 2026-27 | UTA | +2.02 | -0.53 | -1.02 | -0.14 | +0.99 | -0.70 | -0.57 | +2.72 | +0.69 | 98 of 461 |